These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24565527)

  • 21. Drug target identification using side-effect similarity.
    Campillos M; Kuhn M; Gavin AC; Jensen LJ; Bork P
    Science; 2008 Jul; 321(5886):263-6. PubMed ID: 18621671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linear and Kernel Model Construction Methods for Predicting Drug-Target Interactions in a Chemogenomic Framework.
    Yamanishi Y
    Methods Mol Biol; 2018; 1825():355-368. PubMed ID: 30334213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic Variation and Pharmacokinetics in Old Age: A Quantitative Review of Age- vs. Genotype-Related Differences.
    Dücker CM; Brockmöller J
    Clin Pharmacol Ther; 2019 Mar; 105(3):625-640. PubMed ID: 29498032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive prediction of drug-protein interactions and side effects for the human proteome.
    Zhou H; Gao M; Skolnick J
    Sci Rep; 2015 Jun; 5():11090. PubMed ID: 26057345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile.
    van Laarhoven T; Marchiori E
    PLoS One; 2013; 8(6):e66952. PubMed ID: 23840562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectively Identifying Compound-Protein Interactions by Learning from Positive and Unlabeled Examples.
    Cheng Z; Zhou S; Wang Y; Liu H; Guan J; Chen YP
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(6):1832-1843. PubMed ID: 28113437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice.
    Pilotto A; Panza F; Seripa D
    Curr Drug Metab; 2011 Sep; 12(7):621-34. PubMed ID: 21495974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug bioactivation, covalent binding to target proteins and toxicity relevance.
    Zhou S; Chan E; Duan W; Huang M; Chen YZ
    Drug Metab Rev; 2005; 37(1):41-213. PubMed ID: 15747500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting drug side-effect profiles: a chemical fragment-based approach.
    Pauwels E; Stoven V; Yamanishi Y
    BMC Bioinformatics; 2011 May; 12():169. PubMed ID: 21586169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combinations of protein-chemical complex structures reveal new targets for established drugs.
    Kalinina OV; Wichmann O; Apic G; Russell RB
    PLoS Comput Biol; 2011 May; 7(5):e1002043. PubMed ID: 21573205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacogenetics and prediction of side effects of drugs].
    Harrak M; Khabbal Y; Amarti A; El Hassouni M; Ouldim K
    Ann Biol Clin (Paris); 2014; 72(4):405-12. PubMed ID: 25119798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics and adverse drug reactions.
    Meyer UA
    Lancet; 2000 Nov; 356(9242):1667-71. PubMed ID: 11089838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Project ranks billions of drug interactions.
    Reardon S
    Nature; 2013 Nov; 503(7477):449-50. PubMed ID: 24284710
    [No Abstract]   [Full Text] [Related]  

  • 34. Modified linear regression predicts drug-target interactions accurately.
    Buza K; Peška L; Koller J
    PLoS One; 2020; 15(4):e0230726. PubMed ID: 32251481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SELF-BLM: Prediction of drug-target interactions via self-training SVM.
    Keum J; Nam H
    PLoS One; 2017; 12(2):e0171839. PubMed ID: 28192537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of effective drug combinations by chemical interaction, protein interaction and target enrichment of KEGG pathways.
    Chen L; Li BQ; Zheng MY; Zhang J; Feng KY; Cai YD
    Biomed Res Int; 2013; 2013():723780. PubMed ID: 24083237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-target interaction prediction via class imbalance-aware ensemble learning.
    Ezzat A; Wu M; Li XL; Kwoh CK
    BMC Bioinformatics; 2016 Dec; 17(Suppl 19):509. PubMed ID: 28155697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects.
    Chartier M; Morency LP; Zylber MI; Najmanovich RJ
    BMC Pharmacol Toxicol; 2017 Apr; 18(1):18. PubMed ID: 28449705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies to Reduce Solute Carrier-Mediated Toxicity.
    Hu S; Sprowl JA
    Clin Pharmacol Ther; 2018 Nov; 104(5):799-802. PubMed ID: 30028006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A strategy based on protein-protein interface motifs may help in identifying drug off-targets.
    Engin HB; Keskin O; Nussinov R; Gursoy A
    J Chem Inf Model; 2012 Aug; 52(8):2273-86. PubMed ID: 22817115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.